Neurotrophic and neuroprotective effects of class-specific Histone deacetylase (HDAC) inhibitors in cellular models of Parkinson’s disease.

Typeset version

 

TY  - 
  - Unpublished work
  - Collins, L.M., Adriaanse, L., Hegarty, S.V., Sullivan A.M, O’Keeffe, G.W.
  - 2014
  - Unknown
  - Neurotrophic and neuroprotective effects of class-specific Histone deacetylase (HDAC) inhibitors in cellular models of Parkinson’s disease.
  - Author
  - Unpublished
  - 0
  - ()
  - to be submitted to Neuromolecular Medicine)
DA  - 2014/NaN
ER  - 
@unpublished{V277863438,
   = {Unpublished work},
   = {Collins,  L.M. and  Adriaanse,  L. and  Hegarty,  S.V. and  Sullivan A.M,  O’Keeffe and  G.W. },
   = {2014},
   = {Unknown},
   = {Neurotrophic and neuroprotective effects of class-specific Histone deacetylase (HDAC) inhibitors in cellular models of Parkinson’s disease.},
   = {Author},
   = {Unpublished},
   = {0},
   = {()},
   = {{to be submitted to Neuromolecular Medicine)}},
  source = {IRIS}
}
OTHER_PUB_TYPEUnpublished work
AUTHORSCollins, L.M., Adriaanse, L., Hegarty, S.V., Sullivan A.M, O’Keeffe, G.W.
YEAR2014
MONTHUnknown
TITLENeurotrophic and neuroprotective effects of class-specific Histone deacetylase (HDAC) inhibitors in cellular models of Parkinson’s disease.
RESEARCHER_ROLEAuthor
STATUSUnpublished
PEER_REVIEW0
TIMES_CITED()
SEARCH_KEYWORD
REFERENCE
ABSTRACT
PUBLISHER_LOCATION
PUBLISHERto be submitted to Neuromolecular Medicine)
EDITORS
ISBN_ISSN
EDITION
URL
START_PAGE
END_PAGE
DOI_LINK
FUNDING_BODY
GRANT_DETAILS